Arabic Arabic English English French French German German
dark

Neoadjuvant cisplatin, pemetrexed plus atezolizumab followed by surgical resection, maintenance atezolizumab is safe

Neoadjuvant cisplatin and pemetrexed plus atezolizumab followed by surgical resection and maintenance atezolizumab met safety criteria, according to research presented today in OA13: Topics in Pleural Mesothelioma at the IASLC 2021 World Conference on Lung Cancer. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

UKLS trial meta-analysis confirms that low dose CT screening for lung cancer reduces mortality

Next Post

Patients with malignant pleural mesothelioma face barriers to treatment access

Related Posts
Total
0
Share